Virtu KCG Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Virtu KCG Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.24M	Sell	22,205 -54,994	-71%	-$2.99M	0.03%	463
2017 Q1	$4.2M	Buy	77,199 +41,933	+119%	+$2.3M	0.12%	84
2016 Q4	$2.06M	Sell	35,266 -34,999	-50%	-$1.91M	0.05%	301
2016 Q3	$3.79M	Buy	70,265 +14,663	+26%	+$942K	0.09%	127
2016 Q2	$4.09M	Buy	55,602 +51,961	+1,427%	+$3.67M	0.09%	119
2016 Q1	$233K	Sell	3,641 -5,288	-59%	-$333K	0.01%	1939
2015 Q4	$614K	Sell	8,929 -33,601	-79%	-$2.22M	0.01%	1315
2015 Q3	$2.52M	Buy	42,530 +38,974	+1,096%	+$2.47M	0.04%	329
2015 Q2	$237K	Sell	3,556 -87,063	-96%	-$5.74M	﹤0.01%	2382
2015 Q1	$5.84M	Buy	90,619 +63,274	+231%	+$3.96M	0.12%	93
2014 Q4	$1.61M	Sell	27,345 -26,747	-49%	-$1.51M	0.03%	559
2014 Q3	$2.77M	Sell	54,092 -1,502	-3%	-$75K	0.05%	304
2014 Q2	$2.7M	Sell	55,594 -12,942	-19%	-$638K	0.04%	379
2014 Q1	$3.56M	Buy	68,536 +56,230	+457%	+$2.99M	0.04%	389
2013 Q4	$654K	Buy	12,306 +7,513	+157%	+$383K	0.01%	1642
2013 Q3	$222K	Buy	+4,793	New	+$210K	﹤0.01%	2977

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtu KCG Holdings's BMY Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Bristol-Myers Squibb (BMY) stake by 71% in Q2 2017, selling an estimated $2.99M and leaving 22,205 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #463.

Virtu KCG Holdings first reported a position in BMY in Q3 2013 and has held it in 16 quarters since. The position peaked at $5.84M in Q1 2015. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Virtu KCG Holdings held 22,205 shares of Bristol-Myers Squibb worth $1.24M as of Q2 2017.
Virtu KCG Holdings sold 54,994 Bristol-Myers Squibb shares in Q2 2017, an estimated $2.99M.
Bristol-Myers Squibb made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #463 holding.
Virtu KCG Holdings first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 16 quarters since.
Virtu KCG Holdings's Bristol-Myers Squibb position peaked at $5.84M in Q1 2015.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.